跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
爱通立 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Alteplase for Injection
Approved
生物制品
Alteplase for Injection
Boehringer Ingelheim Pharma GmbH & Co. KG
🇨🇳 National Medical Products Administration
Approval Date
Aug 23, 2021
Approval ID
8Dqlfqb2unC
Company
Boehringer Ingelheim Pharma GmbH & Co. KG
Type
生物制品
Approval Details
Approval Id
8Dqlfqb2unC
Approval Number
国药准字SJ20160054
Generic Name
注射用阿替普酶
Generic Name En
Alteplase for Injection
Trade Name
爱通立
Drug Type
生物制品
Dosage Form
注射剂
Strength
20mg/支
Reg Date
2021-08-23
Expired Date
2026-08-22
Company Name
Boehringer Ingelheim Pharma GmbH & Co. KG
Production Company Name
Boehringer Ingelheim Pharma GmbH & Co. KG
Company Detail Path
/organization/boehringer-ingelheim-pharma-gmbh-and-co-kg
Production Company Detail Path
/organization/boehringer-ingelheim-pharma-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 23, 2021
Approval ID
8Dqlfqb2unC
Type
生物制品
Back to NMPA Approvals